+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Biliary Cirrhosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767299
  • Report
  • 93 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Albireo Pharma Inc
  • CymaBay Therapeutics Inc
  • Dr. Falk Pharma GmbH
  • Genextra Spa
  • Genfit SA
  • Gilead Sciences Inc
  • MORE
The global clinical trial report- “2019 Biliary Cirrhosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Biliary Cirrhosis. It presents in-depth analysis of Biliary Cirrhosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Biliary Cirrhosis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Biliary Cirrhosis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Biliary Cirrhosis

The research work is prepared through extensive and continuous research on Biliary Cirrhosis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Biliary Cirrhosis patients are identified
  • The report includes panorama of Biliary Cirrhosis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Biliary Cirrhosis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Albireo Pharma Inc
  • CymaBay Therapeutics Inc
  • Dr. Falk Pharma GmbH
  • Genextra Spa
  • Genfit SA
  • Gilead Sciences Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Biliary Cirrhosis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Biliary Cirrhosis Clinical Trials by Region
2.2.2 Average Enrollment of Biliary Cirrhosis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Biliary Cirrhosis Treatment, 2019

3. Region wise Biliary Cirrhosis Clinical Trials
3.1 Asia Pacific Biliary Cirrhosis Clinical Trials by Country
3.2 Europe Biliary Cirrhosis Clinical Trials by Country
3.3 North America Biliary Cirrhosis Clinical Trials by Country
3.4 Middle East and Africa Biliary Cirrhosis Clinical Trials by Country
3.5 South and Central America Biliary Cirrhosis Clinical Trials by Country

4. Biliary Cirrhosis Clinical Trial Trends
4.1 Start Year wise Biliary Cirrhosis Clinical Trials
4.2 Phase wise Biliary Cirrhosis Clinical Trials
4.3 Trial Status wise Biliary Cirrhosis Clinical Trials
4.4 Trial Type wise Biliary Cirrhosis Clinical Trials

5. Biliary Cirrhosis Average Enrollment Trends
5.1 Average Enrollment in Biliary Cirrhosis Trials by Year
5.2 Average Enrollment in Biliary Cirrhosis Trials by Phase
5.3 Average Enrollment in Biliary Cirrhosis Trials by Status
5.4 Average Enrollment in Biliary Cirrhosis Trials by Type of Trial

6. Companies Participating in Biliary Cirrhosis Clinical Trials
6.1 Biliary Cirrhosis Trials by Sponsor Type
6.2 Biliary Cirrhosis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Biliary Cirrhosis Trials- Phase 1
7.2 Biliary Cirrhosis Trials- Phase 2
7.3 Biliary Cirrhosis Trials- Phase 3
7.4 Biliary Cirrhosis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Biliary Cirrhosis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Figure 7: North America - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Figure 9: Biliary Cirrhosis Clinical Trials by Phase
Figure 10: Biliary Cirrhosis Clinical Trials by Trial Status
Figure 11: Biliary Cirrhosis Clinical Trials by Type
Figure 12: Biliary Cirrhosis Clinical Trials by Sponsor Type
Figure 13: Biliary Cirrhosis Clinical Trials by Leading Sponsors
Figure 14: Biliary Cirrhosis Average Enrollment by Phase
Figure 15: Biliary Cirrhosis Average Enrollment by Trial Status
Figure 16: Biliary Cirrhosis Average Enrollment by Type
Figure 17: Biliary Cirrhosis- Average Enrolment by Type of Sponsors
Figure 18: Biliary Cirrhosis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Biliary Cirrhosis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Table 5: Europe - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Table 7: North America - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Biliary Cirrhosis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Biliary Cirrhosis Average Enrollment by Phase
Table 15: Biliary Cirrhosis Average Enrollment by Trial Status
Table 16: Biliary Cirrhosis Average Enrollment by Type
Table 17: Biliary Cirrhosis- Average Enrolment by Type of Sponsors
Table 18: Biliary Cirrhosis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Albireo Pharma Inc
  • CymaBay Therapeutics Inc
  • Dr. Falk Pharma GmbH
  • Genextra Spa
  • Genfit SA
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • Zambon Company SpA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767299
Adroll
adroll